Business

MedX Health Appoints Global Skin Science Leader Dr. Paul Matts as Strategic Advisor

MedX Health Corp. (TSXV: MDX), “ MedX ” or the “ Company ”), ...

articleMedx Health Corp.September 8, 20253/company/medx-health-corp/news/medx-health-appoints-global-skin-science-leader-dr-paul-matts-as-strategic-advisor
MedX Health Appoints Global Skin Science Leader Dr. Paul Matts as Strategic Advisor

About this update from Medx Health Corp.

[{"type":"text","content":"MedX Health Appoints Global Skin Science Leader Dr. Paul Matts as Strategic Advisor\n\n\n .bwalignc { text-align: center; list-style-position: inside }\n \n\n\n\n MedX Health Corp. (TSXV: MDX), “\n \n MedX\n \n ” or the “\n \n Company\n \n ”), a global leader in teledermatology and non-invasive skin analysis, today announced the appointment of Dr. Paul J. Matts, internationally recognized skin scientist, biochemist and educator, as Strategic Advisor to the Company.\n \n\n Dr. Matts joined Procter & Gamble (P&G) in 1988 as a PhD biochemist and then spent more than three decades in the company’s Research & Development (R&D) divisions, where he applied his expertise to develop breakthrough measures of skin condition, optics and health. Across his 36 year career, he drove serial innovation across some of P&G’s most iconic brands in skin care, colour cosmetics, personal cleansing, hand and body care, and was sought out as a consultant for projects across P&G’s other product categories. He retired in 2024 as R&D Vice President and was honoured as a member of P&G’s Victor Mills Society, the company’s most prestigious recognition for scientific innovation.\n \n\n A global authority on human skin optics, stratum corneum biology, sun protection and the psychology of skin perception, Dr. Matts has authored over 65 peer-reviewed publications, delivered more than 150 keynote presentations worldwide and is widely recognized as a leader in both dermatology and cosmetic science. His pioneering work on MedX’s technology, Spectrophotometric Intracutaneous Analysis (SIAscopy®) enabled, for the first time, the simultaneous, non-invasive measurement of melanin, hemoglobin and collagen, driving powerful new application in both the early detection of malignant melanoma skin cancer and the cosmetic sciences.\n \n\n Dr. Matts has been a leader in the development of standardized global test methods for sun protection since 1993, at European Trade Association level (as the Chairman of the Cosmetics Europe (CE) Sun Protection Methods Task Force and then the Chairman of the CE Sun Protection Strategic Advisory Group) and at International Standards Organisation level (as the UK expert to the ISOTC217/WG5 working group, that has now developed and deploye...

More updates from Medx Health Corp.